Laurus Labs Ltd.

View in App
451.05 +1.05 ▲0.2%

02 May 2024, 02:09:57 PM
Volume: 1,038,836

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lauruslabs.com
Market Cap 24,388.21 Cr.
Enterprise Value(EV) 26,794.03 Cr. 2024-03
Financial Indicators
Earnings per share (EPS) 2.98 Trailing Twelve Months Ending 2024-03
Price-Earning Ratio (PE) 151.90 Trailing Twelve Months Ending 2024-03
Industry PE 42.19 Trailing Twelve Months Ending 2024-03
Book Value / Share 76.27 Trailing Twelve Months Ending 2024-03
Price to Book Value 5.93 Calculated using Price: 452.50
Dividend Yield 0.18 Period Ending 2023-03
No. of Shares Subscribed 53.90 Cr. 538,965,858 Shares
FaceValue 2
About Laurus Labs Ltd.
Laurus Labs offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

Laurus Labs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Laurus Labs Ltd. Performance

View details >>
1 Day
+0.23%
1 Week
+4.14%
1 Month
+14.96%
3 Month
+21.81%
6 Month
+24.82%
1 Year
+46.64%
2 Year
-22.68%
5 Year
+489.92%
10 Year

Laurus Labs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.47 18.65 18.12 11.97 6.19 15.39 45.15 28.05 21.63
Return on Capital Employed (%) 13.74 16.35 16.52 13.68 8.22 14.14 39.82 25.97 22.97
Return on Assets (%) 4.31 6.61 8.05 6.04 3 7.34 20.87 13.09 10.89

Laurus Labs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2024-03* Rs. Cr.
Shh. Funds 722 857 1,330 1,483 1,558 1,770 2,598 3,351 4,038 4,111
Non Curr. Liab. 364 428 132 174 295 214 693 928 1,179 1,159
Curr. Liab. 802 884 1,121 1,307 1,424 1,692 2,457 2,681 2,432 3,112
Minority Int. 3 8 11 5
Equity & Liab. 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968 7,660 8,387
Non Curr. Assets 1,024 1,166 1,444 1,716 1,815 1,864 2,676 3,623 4,199 4,552
Curr. Assets 862 1,003 1,140 1,248 1,463 1,812 3,075 3,345 3,462 3,835
Misc. Exp. not W/O 2
Total Assets 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968 7,660 8,387

Laurus Labs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2024-03 Rs. Cr. TTM
Net Sales 1,327 1,778 1,905 2,056 2,292 2,832 4,814 4,936 6,041 5,041
Other Income 34 4 33 29 16 6 24 15 6 26
Total Income 1,361 1,782 1,938 2,085 2,308 2,838 4,837 4,951 6,047 5,067
Total Expenditure -1,131 -1,415 -1,497 -1,643 -1,936 -2,267 -3,263 -3,513 -4,448 -4,263
PBIDT 229 367 441 443 372 570 1,574 1,438 1,598 804
Interest -101 -111 -100 -80 -88 -90 -68 -102 -165 -183
Depreciation -62 -86 -106 -125 -164 -187 -205 -251 -324 -385
Taxation 2 -35 -44 -70 -26 -38 -317 -251 -312 -68
Exceptional Items
PAT 68 134 191 168 94 255 984 832 797 168
Minority Interest 0 -5 -3 -2
Share Associate 0 0 -1 0 -3 -6
Other Related Items -6
Consolidated Net Profit 68 134 190 168 94 255 984 828 785 161
Adjusted EPS 2 4 4 3 2 5 18 15 15 3

Laurus Labs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 121 -65 182 332 342 298 347 733 911 994
Cash Fr. Inv. -312 -397 -312 -289 -384 -253 -221 -941 -914 -996
Cash Fr. Finan. 203 486 103 -54 42 -45 -128 255 30 -27
Net Change 12 24 -27 -10 1 0 -1 47 27 -29
Cash & Cash Eqvt 15 40 13 2 3 3 2 48 75 46

Laurus Labs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 27.27 27.27 27.27 27.20 27.20 27.20 27.20 27.19 27.19
Public 72.73 72.73 72.73 72.80 72.80 72.80 72.80 72.81 72.81
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.04 0.04 0.04 0.04 0.04 0.04 0.00
No. of Shareholders (in Lacs)

Laurus Labs Ltd. Announcements

View details >>
Tue, 30 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Laurus Labs Limited has informed the Exchange about Transcript
Thu, 25 Apr 2024
Press Release
Laurus Labs Limited has informed the Exchange regarding a press release dated April 25, 2024, titled Press Release Q4 FY 24.
Thu, 25 Apr 2024
Investor Presentation
Laurus Labs Limited has informed the Exchange about Investor Presentation

Laurus Labs Ltd. Technical Scans

View details >>
Tue, 30 Apr 2024
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month

Laurus Labs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,874.59 1,525.65 +1.6%
Cipla Ltd. 114,557.24 1,419.65 +1.4%
Divi's Laboratories Ltd. 104,804.34 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. 104,403.21 6,277.10 +1.2%
Zydus Lifesciences Ltd. 99,214.67 975.75 +2.3%
Mankind Pharma Ltd. 94,488.80 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. 90,090.79 2,684.45 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.08 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-12 30.89 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-12 75.78 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.97 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.36 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-12 54.71 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.30 2,684.45 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.86 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-12 4.42 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-12 8.04 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.26 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.64 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.60 2,684.45 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,684.45 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,684.45 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,684.45 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,684.45 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.65 +1.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,419.65 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,965.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,277.10 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 975.75 +2.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,336.30 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,684.45 +1.6%

Laurus Labs Ltd. FAQ's

What is Laurus Labs share price?
Can I buy Laurus Labs shares now?
What is the Dividend Yield of Laurus Labs?
What is the Market Cap of Laurus Labs?
What are the key metrics to analyse Laurus Labs?
What is the 52 Week High and Low of Laurus Labs?
What is the trend of Laurus Labs share price?